P613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANISM FOLLOWING BTKI THERAPY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA. (2022)

First Author: Kennedy E
Attributed to:  Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/01.hs9.0000845340.78869.11

Publication URI: http://dx.doi.org/10.1097/01.hs9.0000845340.78869.11

Type: Journal Article/Review

Parent Publication: HemaSphere